Danske Bank A S Acquires Shares of 2,152,022 Merck KGaA $MKGAF

Danske Bank A S purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 2,152,022 shares of the company’s stock, valued at approximately $276,535,000. Merck KGaA comprises 0.5% of Danske Bank A S’s portfolio, making the stock its 29th biggest position.

Separately, Gables Capital Management Inc. purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at approximately $2,095,000. Institutional investors own 0.10% of the company’s stock.

Merck KGaA Price Performance

MKGAF stock opened at $160.21 on Wednesday. The firm has a market capitalization of $20.71 billion, a P/E ratio of 24.46 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a 50 day moving average of $162.32 and a 200-day moving average of $148.21. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.